Global Market for Erythropoietin: 2015-2020

Madison, New Jersey, April 29, 2016 (Newswire.com) - The global market for erythropoietin drugs has been growing at a CAGR (2015 to 2020) of 1.0% driven by the increasing cases of anemia particularly in kidney diseases and cancer globally.

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

The global market for erythropoietin drugs

Tisha, Marketing

The major players in the biologic erythropoietin drug market are, Amgen, Inc., Johnson & Johnson and Hoffmann-LA Roche.  Sandoz (subsidiary of Novartis International AG), Hospira (subsidiary of Pfizer, Inc.), Biocon, Biosidus, 3SBio, are some of the major biosimilar players across regions. 

The global market for erythropoietin drugs is expected to grow from $7.0 billion in 2014 to $7.4 billion in 2015 at a year-on-year (YOY) growth rate of 5.1%. In addition, the market is expected to grow at a five-year CAGR (2015 to 2020) of 1.0%, to reach $7.8 billion in 2020.

The major players in the erythropoietin market are Amgen Inc., Dr. Reddys Labs Ltd, Biocon (India) Ltd, Roche, Zydus Cadila Healthcare Ltd, Johnson & Johnson, Ranbaxy Laboratories Ltd, Shantha Biotechnics Pvt Ltd and Emcure Pharmaceuticals Ltd. The “Global market for erythropoietin, 2020” discusses the following aspects of global erythropoietin market.

• Global erythropoietin market size, share & forecast
• Segmental analysis of erythropoietin, by type, by application and region.
• Competitive vendor’s landscape and company SWOT analysis.

For Full Report Browse

http://www.ceskaa.com/shop/new-research-2/global-market-for-erythropoietin-report-2015-2020/

For Free Sample

http://www.ceskaa.com/download-sample-2/

For More Reports

http://www.ceskaa.com/

Source: Ceskaa Market Research